Mylan gets approval pediatric HIV/AIDS therapy

Mylan gets approval for pediatric HIV/AIDS therapy

12:04 AM, 24th February 2012
Mylan gets approval for pediatric HIV/AIDS therapy
Heather Bresch, CEO, Mylan.

PITTSBURGH, US: Mylan Inc announced that its subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Ltd) has received tentative approval from US Food and Drug Administration under the President’s Emergency Plan for AIDS Relief (PEPFAR) for its new drug application (NDA) for Abacavir Sulfate and Lamivudine tablets, 60 mg/30 mg. This fixed-dose combination product was developed for use in treating children with HIV/AIDS and is based on the adult-strength.

Abacavir Sulfate and Lamivudine Tablets are used in combination with other medications to control HIV infection. Mylan also has received approval for this pediatric FDC therapy from the World Health Organization under their prequalification of medicines programme. The product will be eligible for purchase outside US in certain developing countries. “The approval of Abacavir Sulfate and Lamivudine further supports Mylan’s mission to continue expanding access to high quality medicine around the world, which is especially crucial for children living with HIV/AIDS. This product combines two medications in one tablet, which may support treatment adherence in children as it reduces the pill burden often associated with complex antiretroviral regimens,” said Heather Bresch, CEO, Mylan.

© WOC News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


A stomach friendly bitter beer on the cards

VIENNA, AUSTRIA: New researches have report that the bitter acids derived from hops are key players in stimulating gastric acid secretion. When the be ...

Read more
Lanxess to build leather chemicals plant in South Africa

NEWCASTLE, SOUTH AFRICA: Lanxess is investing €40 million to build a CO2 concentration unit at Newcastle, South Africa. At this site, the group o ...

Read more
Novozymes introduces new enzyme for advanced biofuels

BAGSVAERD, DENMARK: Novozymes unveiled its latest innovation, Novozymes Cellic CTec3 enzyme that decreases costs and increases yields in production of ...

Read more
Shell announces new upstream international director, Andrew Brown

HAGUE, THE NETHERLANDS: Shell announced that Malcolm Brinded has agreed to step down as an Executive Director of the company effective from 1 April 20 ...

Read more
BHP Billiton to temporarily suspend production at TEMCO1 facility

MELBOURNE, AUSTRALIA: BHP Billiton announced that it has intention to temporarily suspend production at TEMCO1, its manganese alloy production facilit ...

Read more
Chesapeake Appalachia fined $565,000 for multiple violations of natural gas production

WEST VIRGINIA, US: The Pennsylvania Department of Environmental Protection (DEP) has fined Chesapeake Appalachia LLC a total of $565,000 in civil pena ...

Read more